Levels of trkA and BDNF mRNA, but not NGF mRNA, fluctuate across the estrous cycle and increase in response to acute hormone replacement

Brain Research

Volumn 787, Issue 2, 1998, Pages 259-268

  Gibbs, Robert B ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Aging; Alzheimer's disease; Estrogen; NGF receptor; Progesterone

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; ESTROGEN; NERVE GROWTH FACTOR; PROGESTERONE; TYROSINE KINASE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESTRUS CYCLE; FEMALE; FOREBRAIN; GRANULE CELL; HIPPOCAMPUS; HORMONE SUBSTITUTION; IN SITU HYBRIDIZATION; MAGNOCELLULAR NUCLEUS; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SEPTUM PELLUCIDUM;

ANIMALS; BRAIN CHEMISTRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; ESTRADIOL; ESTROGENS; ESTRUS; FEMALE; HIPPOCAMPUS; IN SITU HYBRIDIZATION; NERVE GROWTH FACTORS; OVARIECTOMY; PREGNANCY; PROGESTERONE; PROSENCEPHALON; PROTO-ONCOGENE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TRKA; RECEPTORS, NERVE GROWTH FACTOR; RNA PROBES; RNA, MESSENGER;

EID: 0032559883     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01511-4     Document Type: Article

References (46)

1. Bothwell M. Functional interactions of neurotrophins and neurotrophin receptors. Annu. Rev. Neurosci. 18:1995;223-253.
2. 125I]nerve growth factor by cholinergic neurons and down-regulated TrkA expression in the medial septum of aged rats. Neuroscience. 62(3):1994;625-629.
3. Courtney M.J., Åkerman K.E.O., Coffey E.T. Neurotrophins protect cultured cerebellar granule neurons against the early phase of cell death by a two-component mechanism. J. Neurosci. 17.11:1997;4201-4211.
4. Dawbarn D., Allen S.J., Semenenko F.M. Coexistence of choline acetyltransferase and nerve growth factor receptors in the rat basal forebrain. Neurosci. Lett. 94:1988;138-144.
5. Fibiger H.C. Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. TINS. 14(6):1991;220-223.
6. R.B. Gibbs, Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function, Exp. Neurol. (in press).
7. Gibbs R.B. Effects of estrogen on basal forebrain cholinergic neurons vary as a function of dose and duration of treatment. Brain Res. 757:1997;10-16.
8. R.B. Gibbs, Estrogen and nerve growth factor-related systems in brain: Effects on basal forebrain cholinergic neurons and implications for learning and memory processes and aging, in: Ed. V.N. Luine, C.F. Harding (Eds.), Hormonal Restructuring of the Adult Brain: Basic and Clinical Perspectives, 743, New York Acad. Sci., NY, 1994, pp. 165-199.
9. Gibbs R.B. Fluctuations in relative levels of choline acetyltransferase mRNA in different regions of the rat basal forebrain across the estrus cycle: Effects of estrogen and progesterone. J. Neurosci. 16(3):1996;1049-1055.
10. Gibbs R.B., Hashash A., Johnson D.A. Effects of estrogen on potassium-evoked acetylcholine release in the hippocampus and overlying cortex of adult rats. Brain Res. 749(1):1997;143-146.
11. NGFR and ChAT expression in the medial septum and diagonal band of Broca. Exp. Neurol. 116:1992;23-39.
12. NGFR and up-regulation by nerve growth factor. J. Comp. Neurol. 341:1994;324-339.
13. Gibbs R.B., Wu D.-H., Hersh L., Pfaff D.W. Effects of estrogen replacement on relative levels of ChAT, TrkA and nerve growth factor messenger RNAs in the basal forebrain and hippocampal formation of adult rats. Exp. Neurol. 129(1):1994;70-80.
14. Henderson V.W. The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology. 48:1997;S27-S35. Suppl. 7.
15. Henderson V.W., Watt L., Buckwalter J.G. Cognitive skills associated with estrogen replacement in women with Alzheimer's disease. Psychoneuroendocrinology. 21(4):1996;421-430.
16. Honjo H., Tanaka K., Kashiwagi T., Urabe M., Hayashi O.M., Hayashi K. Senile dementia - Alzheimer's type and estrogen. Horm. Metab. Res. 27:1994;204-207.
17. Hyman C., Juhasz M., Jackson C., Wright P., Ip N.Y., Lindsay R.M. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14(1):1994;335-347.
18. Isackson P.J., Towner M.D., Huntsman M.M. Comparison of mammalian, chicken and Xenopus brain-derived neurotrophic factor coding sequences. FEBS. 285(2):1991;260-264.
19. Jorm A.F., Korten A.E., Henderson A.S. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr. Scand. 76:1987;465-479.
20. Knüsel B., Beck K.D., Winslow J.W., Rosenthal A., Burton L.E., Widmer H.R., Nikolics K., Hefti F. Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J. Neurosci. 12(11):1992;4391-4402.
21. Korte M., Carroll P., Wolf E., Brem G., Thoenen H., Bonhoeffer T. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc. Nat. Acad. Sci. U.S.A. 92:1995;8856-8860.
22. Korte M., Griesbeck O., Gravel C., Carroll P., Staigner V., Thoenen H., Bonhoeffer R. Virus-mediated gene-transfer into hippocampal CA1 region restores LTP in BDNF-mutant mice. Proc. Nat. Acad. Sci. U.S.A. 93:1996;12547-12552.
23. Lindsay R.M., Alderson R.F., Friedman B., Ip C.H. The neurotrophin family of NGF-related neurotrophic factors. Restor. Neurol. Neurosci. 2:1991;211-220.
24. Luine V.N. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp. Neurol. 89:1985;484-490.
25. Mamounas L.A., Blue M.E., Siuciak J.A., Altar C.A. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J. Neurosci. 15(2):1995;7929-7939.
26. McAllister A.K., Katz L.C., Lo D.C. Neurotrophin regulation of cortical dendritic growth required activity. Neuron. 17:1996;1057-1064.
27. McEntee W.J., Crook T.H. Cholinergic function in the aged brain: implications for treatment of memory impairments associated with aging. Behav. Pharmacol. 3:1992;327-336.
28. McMillan P.J., Singer C.A., Dorsa D.M. The effects of ovariectomy and estrogen replacement on trkA and choline acetyltransferase mRNA expression in the basal forebrain of adult female Sprague-Dawley rat. J. Neurosci. 16(5):1996;1860-1865.
29. Mufson E.J., Lavine N., Jaffar S., Kordower J.H., Quirion R., Saragovi H.U. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp. Neurol. 146(1):1997;91-103.
30. Mufson E.J., Li J.-M., Sobreviela T., Kordower J.H. Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease. NeuroReport. 8:1996;25-29.
31. Nonomura T., Hatanaka H. Neurotrophic effect of brain-derived neurotrophic factor on basal forebrain cholinergic neurons in culture from postnatal rats. Neurosci. Res. 14:1992;226-233.
32. Nonomura T., Nishio C., Lindsay R.M., Hatanaka H. Cultured basal forebrain cholinergic neurons from postnatal rats show both overlapping and non-overlapping responses to the neurotrophins. Brain Res. 683:1995;129-139.
33. Ohkura T., Isse K., Akazawa K., Hamamoto M., Yaoi Y., Hagino N. Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports. Dementia. 6:1995;99-107.
34. Ohkura T., Isse K., Akazawa K., Hamamoto M., Yaoi Y., Hagino N. Low-dose estrogen replacement therapy for Alzheimer disease in women. Menopause. 1(3):1994;125-130.
35. Olton D.S. Dementia: animal models of the cognitive impairments following damage to the basal forebrain cholinergic system. Brain Res. Bull. 25:1990;499-502.
36. Paganini-Hill A., Henderson V.W. Estrogen replacement therapy and risk of Alzheimer's disease. Arch. Intern. Med. 156:1996;2213-2217.
37. Patterson S.L., Abel T., Deuel T.A.S., Martin K.C., Rose J.C., Kandel E.R. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron. 16:1996;1137-1145.
38. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Atlas, 2nd edn., Academic Press, London, 1986.
39. Phillips H.S., Hains J.M., Armanini M., Laramee G.R., Johnson S.A., Winslow J.W. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron. 7:1991;695-702.
40. Singh M., Meyer E.M., Millard W.J., Simpkins J.W. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res. 644:1994;305-312.
41. Singh M., Meyer E.M., Simpkins J.W. The effects of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology. 136(5):1995;2320-2324.
42. Sohrabji F., Miranda R.C., Toran-Allerand C.D. Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J. Neurosci. 14(2):1994;459-471.
43. Tang M.-X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432.
44. Weinstock M. The pharmacotherapy of Alzheimer's disease based on the cholinergic hypothesis: an update. Neurodegeneration. 4:1995;349-356.
45. Widmer H.R., Knüsel B., Hefti F. BDNF protection of basal forebrain cholinergic neurons after axotomy: complete protection of p75NGFR-positive cells. NeuroReport. 4:1993;363-366.
46. Yurek D.M., Lu W., Hipkens S., Weigand S.J. BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons. Exp. Neurol. 137:1996;105-118.